Assignee
OWP PHARMACEUTICALS INC
US·11 granted patents·6 pending applications·6 citations·filing 2020–2025
Top patents by PatentIndex Score
17 records- 0192US11197823B2Topiramate oral liquid suspension and use thereofOWP PHARMACEUTICALS INC·Filed 2020·Granted Dec 14, 2021·3 cites·23 claims
- 0288US11197825B2Topiramate oral liquid suspension and use thereofOWP PHARMACEUTICALS INC·Filed 2020·Granted Dec 14, 2021·2 cites·26 claims
- 0382US11596634B2Lamotrigine oral liquid suspension and use thereofOWP PHARMACEUTICALS INC·Filed 2020·Granted Mar 7, 2023·1 cites·25 claims
- 0481US12594241B2Topiramate oral liquid suspension and use thereofOWP PHARMACEUTICALS INC·Filed 2023·Granted Apr 7, 2026·0 cites·29 claims
- 0578US2024342183A1Lamotrigine oral liquid suspension and use thereofOWP PHARMACEUTICALS INC·Filed 2024·Application pending·0 cites
- 0676US2024082259A1Quetiapine oral liquid suspension and use thereofOWP PHARMACEUTICALS INC·Filed 2023·Application pending·0 cites
- 0773US11759421B2Topiramate oral liquid suspension and use thereofOWP PHARMACEUTICALS INC·Filed 2021·Granted Sep 19, 2023·0 cites·21 claims
- 0873US2023190759A1Lamotrigine oral liquid suspension and use thereofOWP PHARMACEUTICALS INC·Filed 2023·Application pending·0 cites
- 0970US11813269B2Quetiapine oral liquid suspension and use thereofOWP PHARMACEUTICALS INC·Filed 2021·Granted Nov 14, 2023·0 cites·25 claims
- 1065US11872309B2Topiramate oral liquid suspension and use thereofOWP PHARMACEUTICALS INC·Filed 2021·Granted Jan 16, 2024·0 cites·23 claims
- 1165US11045481B2Quetiapine oral liquid suspension and use thereofOWP PHARMACEUTICALS INC·Filed 2020·Granted Jun 29, 2021·0 cites·26 claims
- 1265US2024398763A1Oral dosage form containing oncological active ingredientOWP PHARMACEUTICALS INC·Filed 2024·Application pending·0 cites
- 1364US2024197631A1Atomoxetine oral solutionOWP PHARMACEUTICALS INC·Filed 2023·Application pending·0 cites
- 1464US2024173315A1Trazodone oral solutionOWP PHARMACEUTICALS INC·Filed 2023·Application pending·0 cites
- 1551US12491157B1Atomoxetine hydrochloride oral suspension and use thereofOWP PHARMACEUTICALS INC·Filed 2025·Granted Dec 9, 2025·0 cites·30 claims
- 1651US12478584B1Atomoxetine hydrochloride oral suspension and use thereofOWP PHARMACEUTICALS INC·Filed 2025·Granted Nov 25, 2025·0 cites·30 claims
- 1751US11612566B2Lamotrigine oral liquid suspension and use thereofOWP PHARMACEUTICALS INC·Filed 2020·Granted Mar 28, 2023·0 cites·26 claims
Join the waitlist — get patent alerts
Get an alert when OWP PHARMACEUTICALS INC files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →